All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
EquityFollow-ons and Rights issues

London biotech firm to fund growth with cap hike

medical right size

UK biotech firm Retroscreen Virology on Wednesday raised £33.6m through a sale of shares to new and existing investors that will allow the firm to fund its upcoming projects.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree